Clinical Trials Browser

Enrolling by invitation × Carcinoma, Non-Small-Cell Lung × Clear all

NCT06885424 2026-05-20

DESCENT-1

Enrolling by invitation

BreastGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT07218003 2026-05-04

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Phase 1 Enrolling by invitation

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT00068003 2026-05-01

Harvesting Cells for Experimental Cancer Treatments

Enrolling by invitation

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms

NCT06281964 2026-04-23

KANNON-2

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06730685 2026-02-12

PHILUCA

Enrolling by invitation

Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma, Sarcopenia

NCT06250777 2026-02-09

ELPIS

Phase 2 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT06332131 2026-02-09

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

Enrolling by invitation

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cardiotoxicity

NCT07373951 2026-01-29

DL-DriverBM

Enrolling by invitation

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT06370416 2026-01-28

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Phase 2 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT01385722 2025-12-26

Molecular Analysis of Thoracic Malignancies

Enrolling by invitation

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms

NCT07301983 2025-12-24

LALC

Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04945317 2025-12-17

ROSE/NoROSE

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT07285434 2025-12-16

Microlyvaq™

Phase EARLY_PHASE1 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT06603987 2025-11-19

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Phase 1/2 Enrolling by invitation

BreastGastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neurofibrosarcoma

NCT07214441 2025-10-09

Evaluating the Feasibility and Preliminary Effects of BE+

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Motor Activity

NCT06997458 2025-05-30

LOLA-PROJECT

Enrolling by invitation

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Colorectal Neoplasms

NCT06962449 2025-05-08

REALM-Post

Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Disease Progression

NCT06690216 2025-03-30

PD-L1-PET

Phase 1/2 Enrolling by invitation

CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma

NCT06883136 2025-03-19

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT06876675 2025-03-14

LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer

Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Hyperlipidemias

NCT06759857 2025-01-06

FHND9041

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT06752395 2025-01-03

Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05212103 2024-12-04

CANSI

Enrolling by invitation

DermatologicOther hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Leukemia, Myeloid, Acute

NCT06610240 2024-11-13

Peri-R

Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT06028412 2024-10-15

Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT05863013 2024-05-16

Use of the ADL-Glittre Test in the Pre and Postoperative Period of Patients With Lung Cancer

Phase NA Enrolling by invitation

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04762459 2022-02-24

APEX

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung